Jim Cramer Shares His Thoughts On Gilead Sciences, Inc. And Citigroup Inc
On CNBC's Mad Money, Jim Cramer said that Gilead Sciences, Inc. (NASDAQ: GILD) has to do an acquisition. Without it, the stock is not going to move higher, because the company has a lot of cash and not a lot of growth.
Cramer thinks Citigroup Inc (NYSE: C) was well prepared for the stress test, and he believes it is a buy at its current price.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.